Search - tctmd.com

Displaying 21 - 40 of 260

Sort: Relevancy | Date

Presentation THT 2025

Case Presentation: Decompensated BiV Failure PT

Presenter: Elissa Driggin

February 12, 2025

Presentation THT 2025

TORVAD: A Toroidal, Pulsatile Flow LVAD

Presenter: Richard Smalling

February 12, 2025

Presentation THT 2025

The Future of BiV Failure: BiVACOR

Presenter: Joseph Rogers

February 12, 2025

Presentation THT 2025

Syncardia Total Artificial Heart: Current Outcomes as a Foundation for a New, Fully Implantable Total Artificial Heart

Presenter: Andre Simon

February 12, 2025

Presentation THT 2025

A Device Designed for Patient Comfort - BrioVAD

Presenter: Jim Long

February 12, 2025

Presentation THT 2025

Getting in Sync With CorWave

Presenter: Carl Botterbusch

February 12, 2025

Presentation THT 2025

Debate: Patients Should Go Directly for an LVAD

Presenter: Scott Silvestry

February 12, 2025

Presentation THT 2025

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Presenter: Katherine Wood

February 12, 2025

Presentation THT Abstracts 2025

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Presenter: Kanika Mody

February 11, 2025

Presentation THT Abstracts 2025

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation THT Abstracts 2025

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Presenter: Stavros Drakos

February 11, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

Presentation THT 2025

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Presenter: Mazen Hanna

February 11, 2025

Presentation Miami Valves 2025

Percutaneous Stenting of Severe LVAD Outflow Graft Obstruction

Presenter: Nicholas J. Ruggiero II

January 30, 2025

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Todd Neale

January 23, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

Presentation TCT 2024

TAVR for LVAD-Associated AR

Presenter: Ravi Ramana

October 30, 2024

Advertisement

Case Presentation: Decompensated BiV Failure PT

TORVAD: A Toroidal, Pulsatile Flow LVAD

The Future of BiV Failure: BiVACOR

Syncardia Total Artificial Heart: Current Outcomes as a Foundation for a New, Fully Implantable Total Artificial Heart

A Device Designed for Patient Comfort - BrioVAD

Getting in Sync With CorWave

Debate: Patients Should Go Directly for an LVAD

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Barostim With Durable Left Ventricular Assist Device (LVAD) Therapy

The Use of Cardiac Contractility Modulation(CCM) and Durable Left Ventricular Assist Device (LVAD) for Patients With Class IV CHF

Impact of HF Pharmacological Therapy on the Durability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

HF Etiology and the Sustainability of Favorable Response After LVAD Weaning: A VAD Wean Registry Analysis

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Inotropes, LVADs and Heart Transplant in Amyloid Heart Disease

Percutaneous Stenting of Severe LVAD Outflow Graft Obstruction

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

November 2024 Dispatch for the CV Team

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

TAVR for LVAD-Associated AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content